BCIDP Prep Course (BCIDP)

$150.00

Pharmacists preparing for the BPS Board Certified Infectious Diseases Pharmacist (BCIDP) exam, including clinical pharmacists, PGY2 infectious diseases pharmacy residents, and practicing pharmacists seeking board certification or recertification-aligned mastery. Key goals: By the end of this course, learners will be able to:; Explain the BCIDP exam content domains/competency areas and how each lesson maps to them, without relying on unpublished weighting or hidden blueprint details..

Includes: Lessons + Flashcards + QBank

Exam: Board Certified Infectious Diseases Pharmacist (BCIDP) · Organization: Board of Pharmacy Specialties (BPS)

SKU: MEDEXP-COURSE-8465 Category: Brand:

Description

BCIDP Prep Course (BCIDP)

Pharmacists preparing for the BPS Board Certified Infectious Diseases Pharmacist (BCIDP) exam, including clinical pharmacists, PGY2 infectious diseases pharmacy residents, and practicing pharmacists seeking board certification or recertification-aligned mastery. Key goals: By the end of this course, learners will be able to:; Explain the BCIDP exam content domains/competency areas and how each lesson maps to them, without relying on unpublished weighting or hidden blueprint details..

Exam: Board Certified Infectious Diseases Pharmacist (BCIDP) · Organization: Board of Pharmacy Specialties (BPS)

Includes: Lessons + Flashcards + QBank

Audience: Pharmacists preparing for the BPS Board Certified Infectious Diseases Pharmacist (BCIDP) exam, including clinical pharmacists, PGY2 infectious diseases pharmacy residents, and practicing pharmacists seeking board certification or recertification-aligned mastery.

Goals:

  • By the end of this course, learners will be able to:
  • Explain the BCIDP exam content domains/competency areas and how each lesson maps to them, without relying on unpublished weighting or hidden blueprint details.
  • Master high-yield infectious diseases pharmacotherapy concepts across antimicrobial agents, microbiology/diagnostics, syndrome-based management, stewardship, monitoring, prevention, and special populations.
  • Apply pharmacist-centered clinical reasoning in realistic exam-style scenarios: identify the task, extract key patient and microbiology facts, select the governing pharmacotherapy or stewardship principle, choose the best regimen or modification, and verify efficacy, safety, feasibility, and stewardship alignment.
  • Interpret microbiology, culture, susceptibility, rapid diagnostic, and biomarker data to distinguish colonization vs infection, contamination vs true pathogen, empiric vs targeted therapy needs, and clinically meaningful resistance implications.
  • Design and optimize patient-specific antimicrobial regimens using explicit stepwise reasoning, including drug selection, dose, interval, route, duration, renal/hepatic adjustment when relevant, PK/PD-informed considerations, IV-to-PO transition, de-escalation, and monitoring.
  • Distinguish common exam distractors and boundary cases, including drug-bug mismatch, unnecessary spectrum, duplicate coverage, inappropriate duration, failure to account for organ function or host factors, and omission of key safety monitoring.
  • Use concise comparison tables, checklists, algorithms, and spaced-review summaries to build retrieval-ready memory for high-yield BCIDP content.
  • Demonstrate readiness through self-checks and mini-assessments mapped to BCIDP domains or clearly labeled derived subskills.
  • Coverage & Blueprint Mapping Requirements:
  • Every chapter/section/subsection/topic must map to at least one BCIDP domain/competency area or a clearly labeled derived subskill using a consistent format such as "DOMAIN: Objective -> Subskill".
  • When public blueprint language is broad, translate it into teachable pharmacist-relevant subskills without implying official BPS wording.
  • Ensure complete coverage across exam-relevant infectious diseases pharmacy scope, including antimicrobial agents; microbiology and diagnostics interpretation; infectious syndromes; antimicrobial stewardship; patient-specific regimen design and monitoring; special populations; prevention, prophylaxis, and vaccination-related pharmacist decisions; adverse effects, interactions, contraindications, allergy assessment, toxicity mitigation, and outcomes evaluation.
  • No domain/objective may be left unmapped. If a detail is uncertain or institution-dependent, provide learner-safe guidance such as "Local protocols vary; confirm with your institution" rather than guessing or inserting internal review notes.
  • Keep all teaching and assessment within pharmacist candidate scope: therapeutic evaluation, optimization, monitoring, stewardship, and recommendation quality rather than unsupported independent diagnosis outside pharmacist practice role.
  • Prioritize durable principles and decision frameworks when guidelines or local practices may vary; avoid claiming exact unpublished weightings, scoring rules, or hidden blueprint details.

Access is granted immediately after purchase.